These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22087503

  • 1. Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).
    Khan A, Lewis C, Lindenmayer JP.
    BMC Psychiatry; 2011 Nov 16; 11():178. PubMed ID: 22087503
    [Abstract] [Full Text] [Related]

  • 2. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.
    BMC Psychiatry; 2007 Nov 15; 7():66. PubMed ID: 18005449
    [Abstract] [Full Text] [Related]

  • 3. Disparity between General Symptom Relief and Remission Criteria in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor Item Response Theory Model.
    Anderson AE, Reise SP, Marder SR, Mansolf M, Han C, Bilder RM.
    Innov Clin Neurosci; 2017 Dec 01; 14(11-12):41-53. PubMed ID: 29410936
    [Abstract] [Full Text] [Related]

  • 4. A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis.
    Khan A, Lindenmayer JP, Opler M, Yavorsky C, Rothman B, Lucic L.
    Schizophr Res; 2013 Oct 01; 150(1):185-96. PubMed ID: 23911252
    [Abstract] [Full Text] [Related]

  • 5. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P, Blicher AB, Buus CW, Feller SG, Holm T, Dines D, O'Leary KM, Sørensen RS, Opler M, Correll CU, Mors O, Bech P, Østergaard SD.
    Nord J Psychiatry; 2018 Aug 01; 72(6):431-436. PubMed ID: 30037286
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec 01; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 7. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.
    Levine SZ, Rabinowitz J, Rizopoulos D.
    Psychiatry Res; 2011 Aug 15; 188(3):446-52. PubMed ID: 21463902
    [Abstract] [Full Text] [Related]

  • 8. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D.
    J Nerv Ment Dis; 1992 Nov 15; 180(11):723-8. PubMed ID: 1431824
    [Abstract] [Full Text] [Related]

  • 9. An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric Trials.
    Findling RL, Youngstrom EA, McClellan JM, Frazier JA, Sikich L, Daniel DG, Busner J.
    J Am Acad Child Adolesc Psychiatry; 2023 Apr 15; 62(4):427-434. PubMed ID: 36526163
    [Abstract] [Full Text] [Related]

  • 10. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.
    Østergaard SD, Lemming OM, Mors O, Correll CU, Bech P.
    Acta Psychiatr Scand; 2016 Jun 15; 133(6):436-44. PubMed ID: 26558537
    [Abstract] [Full Text] [Related]

  • 11. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis.
    Siafis S, Brandt L, McCutcheon RA, Gutwinski S, Schneider-Thoma J, Bighelli I, Kane JM, Arango C, Kahn RS, Fleischhacker WW, McGorry P, Carpenter WT, Falkai P, Hasan A, Marder SR, Schooler N, Engel RR, Honer WG, Buchanan RW, Davidson M, Weiser M, Priller J, Davis JM, Howes OD, Correll CU, Leucht S.
    Lancet Psychiatry; 2024 Jan 15; 11(1):36-46. PubMed ID: 38043562
    [Abstract] [Full Text] [Related]

  • 12. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
    Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Kahn RS, Glenthøj BY.
    Psychiatry Res; 2020 Jul 15; 289():112970. PubMed ID: 32438207
    [Abstract] [Full Text] [Related]

  • 13. Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.
    Anderson AE, Mansolf M, Reise SP, Savitz A, Salvadore G, Li Q, Bilder RM.
    Psychiatry Res; 2017 Dec 15; 258():207-216. PubMed ID: 28899614
    [Abstract] [Full Text] [Related]

  • 14. Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room.
    Montoya A, Valladares A, Lizán L, San L, Escobar R, Paz S.
    Health Qual Life Outcomes; 2011 Mar 29; 9():18. PubMed ID: 21447155
    [Abstract] [Full Text] [Related]

  • 15. The reliability and validity of general psychotic rating scales with people with mild and moderate intellectual disabilities: an empirical investigation.
    Hatton C, Haddock G, Taylor JL, Coldwell J, Crossley R, Peckham N.
    J Intellect Disabil Res; 2005 Jul 29; 49(Pt 7):490-500. PubMed ID: 15966956
    [Abstract] [Full Text] [Related]

  • 16. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR.
    JAMA Psychiatry; 2016 Sep 01; 73(9):947-54. PubMed ID: 27438995
    [Abstract] [Full Text] [Related]

  • 17. Relationship of "prodromal" symptoms with severity and type of psychopathology in the active phase of schizophrenia.
    Moukas G, Stathopoulou A, Gourzis P, Beratis IN, Beratis S.
    Compr Psychiatry; 2010 Sep 01; 51(1):1-7. PubMed ID: 19932819
    [Abstract] [Full Text] [Related]

  • 18. [Influence of resistance to voices on depression].
    Monestès JL, Vavasseur-Desperriers J, Villatte M, Denizot L, Loas G, Rusinek S.
    Encephale; 2015 Feb 01; 41(1):25-31. PubMed ID: 24815790
    [Abstract] [Full Text] [Related]

  • 19. French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms.
    Favrod J, Rexhaj S, Ferrari P, Bardy S, Hayoz C, Morandi S, Bonsack C, Giuliani F.
    BMC Psychiatry; 2012 Sep 28; 12():161. PubMed ID: 23020603
    [Abstract] [Full Text] [Related]

  • 20. Polish version of the Brief Negative Symptom Scale (BNSS).
    Wójciak P, Górna K, Domowicz K, Jaracz K, Gołębiewska K, Michalak M, Rybakowski J.
    Psychiatr Pol; 2019 Jun 30; 53(3):541-549. PubMed ID: 31522195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.